Synbias Pharma

Synbias Pharma is a specialty pharmaceutical company dedicated to the development and large-scale production of high-potency Active Pharmaceutical Ingredients (APIs), specifically focusing on anthracycline-based oncology medications. The company is recognized for its expertise in complex chemical synthesis and the manufacturing of critical chemotherapy agents such as doxorubicin, epirubicin, and idarubicin. Operating under strict Good Manufacturing Practice (GMP) standards, Synbias provides high-quality generic substances to pharmaceutical manufacturers and healthcare providers worldwide. Headquartered in Switzerland with historical manufacturing roots in Ukraine, the company supports the treatment of various malignancies including breast cancer, leukemia, and lymphoma. Their business model encompasses both the supply of off-the-shelf APIs and custom synthesis services for global partners.